Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Schneeberg, Amy ^a   Bettinger, Julie A ^a   McNeil, Shelly ^b   Ward, Brian J ^c   Dionne, Marc ^d   Cooper, Curtis ^e   Coleman, Brenda ^f   Loeb, Mark ^g   Rubinstein, Ethan ^h   McElhaney, Janet ^a   Scheifele, David W ^a   Halperin, Scott A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Invasive pneumococcal disease; Older adults; Polysaccharide pneumococcal vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ATTITUDE TO HEALTH; CANADA; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BEHAVIOR; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; MALE; ORGANIZATION; PROCEDURES; PUBLIC HEALTH; QUESTIONNAIRE; RESEARCH; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VACCINATION; VERY ELDERLY;

ACADEMIES AND INSTITUTES; AGED; AGED, 80 AND OVER; CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; ORGANIZATIONS; PNEUMOCOCCAL VACCINES; PUBLIC HEALTH; QUESTIONNAIRES; RESEARCH; VACCINATION;

EID: 84902247922     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-442     Document Type: Article

References (28)

1. Vaccine Preventable Diseases: Invasive Pneumococcal Disease. Public Health Agency of Canada, 2011 http://www.phac-aspc.gc.ca/im/vpd-mev/index-eng. php
2. Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Kohlhammer Y, Schnoor M, Schwartz M, Raspe H, Schäfer T, Public Health 2007 121 742 51 10.1016/j.puhe.2007.02.011 17572457
3. Group ER, Canadian Adult National Immunization Coverage (Adult NICS) Survey 2006
4. Public Health Agency of Canada (PHAC), Canadian Immunization Guide-Public Health Agency of Canada 2007
5. Pfizer Canada Inc, Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) Product Monograph Kirkland 2014
6. Update on the use of conjugate pneumococcal vaccines in childhood. National Advisory Committee on Immunization-Public Health Agency of Canada, Canada Commun Dis Rep 2010
7. The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults. Frenck RW, Yeh S, Expert Opin Biol Ther 2012 12 63 77 10.1517/14712598.2012.636348 22074323
8. The theory of planned behavior. Ajzen I, Organ Behav Hum Decis Process 1991 50 179 211 10.1016/0749-5978(91)90020-T
9. The health belief model: a decade later. Janz NK, Becker MH, Heal Educ Behav 1984 11 1 47 10.1177/109019818401100101
10. A global clinical measure of fitness and frailty in elderly people. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A, CMAJ 2005 173 489 95 10.1503/cmaj.050051 16129869
11. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. Nichol KL, Mac Donald R, Hauge M, J Gen Intern Med 1996 11 673 7 10.1007/BF02600158 9120653
12. Why do older people not get immunised against influenza? a community survey. Evans MR, Watson P, Vaccine 2003 21 2421 2427 10.1016/S0264-410X(03) 00059-8 12744874
13. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001). Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M, J Am Geriatr Soc 2004 52 25 30 10.1111/j.1532-5415.2004.52006.x 14687311
14. Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Ehresmann KR, Ramesh A, Como-Sabetti K, Peterson DC, Whitney CG, Moore KA, Prev Med (Baltim) 2001 32 409 15 10.1006/pmed.2001.0839
15. Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis. Lau D, Hu J, Majumdar SR, Storie DA, Rees SE, Johnson JA, Ann Fam Med 2012 10 538 46 10.1370/afm.1405 23149531
16. Efficacy of pneumococcal vaccination in adults: a meta-analysis. Huss A, Scott P, Stuck AE, Trotter C, Egger M, CMAJ 2009 180 48 58 10.1503/cmaj.080734 19124790
17. Impact of pneumococcal vaccination on morbidity and mortality of geriatic patients: a case-controlled study. Wagner C, Popp W, Posch M, Vlasich C, Rosenberger-Spitzy A, Gerontology 2003 49 4 246 250 10.1159/000070405 12792160
18. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. Sharpiro E, Berg A, Austrian R, Schroeder D, Parcells V, Margolis A, Adair R, JD C, N Engl J Med 1991 325 21 1453 60 10.1056/NEJM199111213252101 1944423
19. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I, Clin Infect Dis 2014 58 909 17 10.1093/cid/ciu002 24532544
20. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the community-acquired pneumonia organi. Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA, Vaccine 2014 32 2198 203 10.1016/j.vaccine.2014.02.048 24613522
21. Adult pneumococcal vaccination: a review of physician and patient barriers. Mieczkowski TA, Wilson SA, Vaccine 2002 20 1383 1392 10.1016/S0264-410X(01)00463-7 11818157
22. Physician practices and attitudes regarding adult immunizations. Szilagyi PG, Shone LP, Barth R, Kouides RW, Long C, Humiston SG, Jennings J, Bennett NM, Prev Med (Baltim) 2005 40 152 61 10.1016/j.ypmed.2004.05.010
23. Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong. Mui LWH, Chan AYS, Lee A, Lee J, PLoS One 2013 8 78210 10.1371/journal.pone. 0078210 24223775
24. Factors associated with pneumococcal and influenza vaccination in hospitalized people aged 65 years. Sintes X, Nebot M, Izquierdo C, Ruiz L, Dominguez A, Bayas JM, Vera I, Carratala J, Sousa D, Epidemiol Infect 2011 139 666 673 10.1017/S0950268810001846 20696084
25. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Christenson B, Lundbergh P, Epidemiol Infect 2002 129 515 24 10.1017/S095026880200780X 12558334
26. Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008. Lu P, Nuorti JP, Am J Prev Med 2010 39 287 95 10.1016/j.amepre.2010.06.004 20837278
27. Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND, Heal Psychol 2007 26 136 45
28. Pneumococcal vaccination in hospitalized elderly patients: role of the pharmacist. Wong-Beringer A, Brodetsky E, Quist R, Pharmacotherapy 2003 23 199 208 10.1592/phco.23.2.199.32085 12587809